Live Breaking News & Updates on Processa Pharmaceuticals Inc
Stay updated with breaking news from Processa pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totalling 47,500 shares, a decline of 91.6% from the April 30th total of 568,300 shares. Based on an average daily volume of 1,410,000 shares, the days-to-cover ratio […] ....
HC Wainwright reaffirmed their buy rating on shares of Processa Pharmaceuticals (NASDAQ:PCSA – Free Report) in a report published on Monday morning, Benzinga reports. HC Wainwright currently has a $8.00 price objective on the stock. HC Wainwright also issued estimates for Processa Pharmaceuticals’ Q2 2024 earnings at ($0.98) EPS, Q3 2024 earnings at ($1.02) EPS, […] ....
HC Wainwright reaffirmed their buy rating on shares of Processa Pharmaceuticals (NASDAQ:PCSA – Free Report) in a report published on Monday, Benzinga reports. HC Wainwright currently has a $8.00 target price on the stock. HC Wainwright also issued estimates for Processa Pharmaceuticals’ Q2 2024 earnings at ($0.98) EPS, Q3 2024 earnings at ($1.02) EPS, FY2024 […] ....
Processa Pharmaceuticals (NASDAQ:PCSA) Receives "Buy" Rating from HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Equities Analysts Set Expectations for Processa Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:PCSA) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.